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Abstract
Background: This paper describes the clinical outcomes from a novel direct access arrhyth-
mia monitoring service.
Methods: The study was carried out in the north of Scotland. Data was collected over
a 29 month period between 18 June 2008 and 8 November 2010 from consecutive cases from
two groups of patients, general practitioner (GP) direct access and ‘redirected’ consultant
referrals. Monitor test results, frequency of arrhythmias requiring further care and clinic
attendances were recorded. Statistical differences were analyzed using c2, Fisher’s and Stu-
dent’s t-test as appropriate with the significance taken at the 0.05 level.
Results: 239 patients were referred from 47 GP practices. There were 165 (69%) referrals
through the ‘direct’ and 72 (31%) through the ‘redirected’ route. The average age was 55.5 ±
± 16.7 years with 84 (35.1%) males. 127 (53.1%) had a patient activated event recording and
the remaining 112 (46.9%) had Holter monitoring. Of the 239 patients, only nine (3.8%) cases
required referral to a consultant cardiologist. Of these, three were directly returned to GP care
without consultant clinic review. Six patients with significant arrhythmias were reviewed at
cardiology clinic. There were no adverse events.
Conclusions: Direct access for cardiac arrhythmia monitoring seems to provide an effective
mechanism for diverting inappropriate or non-essential referrals away from the cardiology
clinic. (Cardiol J 2012; 19, 1: 70–75)
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Introduction
Palpitations and cardiac arrhythmias in patients
are relatively common [1]. The majority of these
patients are managed in primary care. The remain-
der may be referred to secondary care either for
arrhythmia monitoring [2, 3] or clinical review.
Even in this selected group of referred patients,
benign arrhythmias such as ectopic beats and short-
lived narrow complex tachycardia are common
[4, 5]; atrial fibrillation and flutter occur less fre-
quently [6, 7]; and more malignant arrhythmias are
rare [8]. Thus, the bulk of these patients are un-
likely to need specialist cardiology intervention.
However, historically, many of these patients have
been seen in the cardiology clinic, with significant
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resources dedicated to these low risk patients [9].
There remains a significant demand capacity mis-
match in many cardiology clinics. Low risk palpita-
tion patients seem an obvious target to reduce de-
mand on clinical services. Alternatives to referral
of these patients to the cardiology clinic could in-
clude rapid access clinics [8], primary care testing
[9], non-doctor led arrhythmia clinics [10], or open
access services [11].
The healthcare system in this area is predomi-
nantly the United Kingdom’s National Health Ser-
vice (NHS), free at the point of care for patients,
with few private patients. There is a low number of
cardiologists with only four cardiologists in an area
with a dispersed population of ~250,000. There are
no local electrophysiologists, and referral for com-
plex arrhythmias are made to the University Hos-
pital, three hours’ travel time away. Thus, in gene-
ral, demand outstrips capacity in our healthcare
system so there is a drive to create more efficient
ways of working.
In our area, general practitioners (GPs) were
offered direct access to arrhythmia monitoring as an
alternative to the traditional referral pathway through
the cardiology consultant. The aim was to improve
access for patients to monitoring and reduce unneces-
sary referrals to the cardiology clinic.
This paper describes the clinical outcomes
from this service and discusses issues relating to
patient care, waiting times, quality, cost–effective-
ness and the effect on clinical services.
Methods
Setting
The study was carried out at a regional centre in
the north of Scotland serving a population of approxi-
mately 220,000 spread over a large geographical area.
Patient selection
This service was designed for low risk arrhyth-
mia patients. High risk patients were either admit-
ted to hospital or referred urgently for clinic review.
The definition of ‘high risk’ was left to the discretion
of the primary care physician or the consultant cardio-
logist. Data was collected over a 29 month period
between 18 June 2008 and 8 November 2010 from
consecutive cases from two groups of patients, GP
direct access and ‘redirected’ consultant referrals.
‘Redirected’ consultant referrals were those cases
which were initially referred by a GP to a consultant
by letter but ‘redirected’ by the consultant to the
direct access service. Cases were excluded if the test
(24 h Holter or event monitor) was cancelled, or the
patient did not attend or if there was a technical fault
with the monitoring equipment (Fig. 1). All patients
were contacted by phone prior to their appointment
to ensure that the clinical details were accurate, and
to triage patients to a Holter or event monitor.
Monitor analysis
The monitors were analyzed by fully trained
cardiac physiologists who are specialists in cardiac
physiology measurement and interpretation. This
cohort is a recognised health professional grouping
who undergo a four year vocational university ho-
nours degree program and who are registered to
practice under the auspices of the Registration
Council for Clinical Physiologists (RCCP) in the
United Kingdom. Within our unit, we have a total
of seven specialist trained physiologists to govern
this ambulatory service.
Data handling and statistical analysis
Audit forms including arrhythmia monitor re-
sults and patient outcomes were completed pro-
spectively by a senior cardiac physiologist (FD).
Data was then anonymized and transferred to Ex-
cel (Microsoft Inc, USA) for statistical analysis. Sta-
tistical differences were analyzed using c2, Fisher’s
and Student’s t-test as appropriate with the signi-
ficance taken at the 0.05 level.
Waiting times
The waiting time was defined as the difference
between the appointment date and the date of the re-
quest being made. Where the date of request was ab-
Figure 1. Data handling flow diagram, illustrating the
exclusion and classification of available data; DNA —
did not attend; GP — general practitioner.
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sent from the audit forms, the date the request was
received from primary care was used as an alternative.
Outcomes
Arrhythmia monitor results were divided into
one of three categories: ‘negative’, ‘positive’ or ‘sig-
nificant’ (Table 1).
The patient was either sent back to the GP for
management in primary care, or it was decided that
the case required consultant input (Fig. 1). All those
results considered ‘negative’ or ‘positive’ and not
requiring cardiology consultant opinion were sent
directly back to the GP with no consultant input.
All those cases considered ‘significant’ required
consultant opinion. The outcome of the consultant
review was either that the patient was directly re-
turned to primary care, required a clinic appoint-
ment or had a procedure (e.g. implantable loop re-
cording or pacemaker). If a patient had a further
cardiology appointment, but was an existing cardio-
logy patient, then it was assumed that the patient
was attending due to the existing cardiac diagno-
sis. The medical records of patients with significant
arrhythmias or who were subsequently seen in
a new patient cardiology clinic were reviewed.
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Results
A total of 280 patients were referred to the
service from 47 separate GP practices. Of the 280 pa-
tients, 41 (14.6%) cases were excluded (Fig. 1).
The remaining 239 cases were evaluated. There
were 165 (69%) referrals through the direct access
pathway and 72 (31%) via the ‘redirected’ route. In
both cases, event recording was more common than
the Holter (Table 2). Those referred through the
consultant route had a slightly higher number of sig-
nificant arrhythmias that required further consult-
ant advice, although this difference did not reach
statistical significance, suggesting that there was
no systematic difference in the patients referred via
these two routes (6.9 vs 2.4%; p = 0.14).
Demographics, request appropriateness
and waiting times
The average age was 55.5 ± 16.7 years (range
13–92) with 84 (35.1%) males. In 188 (78.7%) cas-
es the request was deemed appropriate, 41 (17.2%)
were not appropriate (i.e. wrong test requested),
while in ten (4.2%) it could not be determined
whether the request was appropriate due to insuf-
ficient data. In 231 (97.5%) cases, a relevant clini-
cal history was given. In the other six cases (2.5%),
there was no clinical history given. However, the
clinical history was deemed insufficient in 36
(15.1%) cases. The median waiting time was 84 days
(IQR 50–112).
Test results and outcomes
Of the 239 completed tests, 127 (53.1%) had
a patient activated event recording and the remain-
ing 112 (46.9%) had Holter monitoring (Table 3).
The average age of patients undergoing Holter
monitoring was higher than that of those undergo-
ing event recording. There was no difference in the
Table 1. Reporting criteria used to categorize the patient results.
Result category Definition
Negative Normal ECG recording with no evidence of abnormality
Positive The general practitioners question was answered but no significant arrhythmia
(e.g. paroxysmal atrial fibrillation, frequent ectopics beats)
Significant Potentially high risk arrhythmia (e.g. ventricular tachycardia, sustained supra-ventricular
tachycardia, > 3 s pauses)
Table 2. Differences between those cases referred via direct access and those referred to the consultant.
General practitioners direct Consultant referral P
referral route (n = 165)  route (n = 72)
Event monitoring procedure (n = 127) 84 (50.6%) 43 (59.7%) 0.21 (c2)
Holter monitoring procedure (n = 110) 81 (48.8%) 29 (40.3%)
Result requiring consultant advice (n = 9) 4 (2.4%) 5 (6.9%) 0.14 (Fisher’s test)
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results of patients who had a Holter compared to
an event monitor. Similarly, there was no difference
in patients’ outcomes between these two monitor-
ing modalities (Table 3).
Of the 239 patients, only nine (3.8%) required
consultant advice, with the remaining 230 (96.2%)
returned directly to be managed by the requesting
GP (Table 4). A further three of these nine cases
were returned to GP care without clinic review.
Patients with significant arrhythmias such as sig-
nificant tachycardia and those involving long paus-
es (> 3 s) were reviewed at cardiology clinic for
further evaluation and management (Table 4).
Followed-up data was available for an average
of 639 ± 246 days (range 216–1,119). Fifty (21%) of
the 239 patients had an outpatient appointment fol-
lowing their arrhythmia monitoring. Nineteen of
these were existing cardiology patients. Of the re-
maining 31 patients, four were seen for ongoing clinic
review. The remaining 27 were all returned to GP
care following cardiology outpatient review. Medi-
cal therapy was prescribed in nine cases (Fig. 2).
Thus, the majority were reviewed by the consultant
and the patient was re-assured with or without
a change in medication and all patients discharged
to the GP for ongoing management. There were no
adverse events in the direct or redirected patient
groups.
Discussion
This paper describes the outcomes of a pilot
project utilizing direct access GP requesting of ar-
rhythmia monitoring. It demonstrated that the vast
majority of patients (96.2%) did not require refer-
ral to a cardiology clinic or consultant input and
there were no reported adverse events. Further-
more, there were no differences in outcomes be-
Table 3. Comparative results and outcomes between event and Holter testing. Data expressed as actual
number (percentage).
Event monitor  (n = 127) Holter monitor  (n = 112) P
Mean age [years] 52.7 ± 17.3 58.8 ± 15.5 0.005 (t-test)
Result:
Negative 52 (40.9%) 50 (44.6%) 0.76 (c2)
Positive 70 (55.1%) 59 (52.7%)
Significant 5 (3.9%) 3 (2.7%)
Outcome:
Back to general practitioners 121 (95.3%) 109 (97.3%) 0.51 (Fisher’s test)
Requiring consultant advice 6 (4.7%) 3 (2.7%)
Table 4. Clinical details and outcomes of ‘significant’ arrhythmia cases requiring consultant advice.
Test Age Gender Specific arrhythmia Outcome after Final outcome
consultant case review
Event 53 F Paroxysmal AF with fast ventri- Back to GP with advice No further action
cular conduction up to 200 bpm
Event 83 F AV nodal re-entry tachycardia Back to GP with advice No further action
Event 67 F Self terminating VT Clinic review Given option of ablation
or medical therapy
Event 69 F SVT (220 bpm max) Clinic review Referred for EP studies
Event 32 F SVT (250 bpm) Clinic review Beta-blocker prescribed
ablation offered
Event 32 F SVT (214 bpm) Clinic review No further action
Holter 70 M Prolonged QT interval Back to GP with advice No further action
and short runs of VT
Holter 85 M Self terminating VT Clinic review Pacemaker inserted
Holter 70 F AF and 4 s pause Clinic review Pacemaker inserted
AF — atrial fibrillation; AV — atrio-ventricular; EP — electrophysiological; F — female; GP — general practitioner; M — male; SVT — supra-ventricular
tachycardia; VT — ventricular tachycardia;
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tween the GP ‘direct access’ and the consultant ‘re-
directed’ groups, suggesting that the threshold for
referring patients was not reduced by the availabi-
lity of the direct access service. There were no ad-
verse events and thus the direct access service
appeared to achieve its aim of safely reducing un-
necessary referral of low risk patients with palpita-
tions to the cardiology clinic. However, despite the
availability of the service, many GPs still referred
low risk patients directly to consultants. Therefore
better advertising or policing of this service is clear-
ly required to maximize the potential benefits.
Benign cardiac arrhythmias and palpitations are
common, with over one million people in the UK,
or one in 85 people, having experienced an arrhyth-
mia [12]. The majority of patients can be safely re-
assured based on a review of the symptoms and clini-
cal examination, while others may require resting
ECGs and further arrhythmia monitoring. Our study
has shown that malignant arrhythmia was rare even
in those referred to secondary care. Of the 239 cas-
es, only two required a pacemaker insertion and
three patients were considered for ablation, de-
monstrating that a small proportion of patients re-
ferred for arrhythmia monitoring required more
aggressive therapies.
There were 19 patients who were referred to
the cardiology clinic after initially being sent back
to the GP for management after direct access test-
ing. All of these patients were discharged back to
GP care after a single cardiology clinic visit, sug-
gesting that no worrying long term arrhythmia or
cardiac condition was missed. Using the direct ac-
cess service in these patients may (or may not) have
caused a delay to achieving consultant review, but
arguably the overall benefit to the service would
outweigh the possible delay in seeing a small num-
ber of low risk patients.
The median waiting time remained long at
84 days. There was a wide and unexplained range
(0–285 days) demonstrating a considerable varia-
tion in waiting times for patients. In particular, the
Holter monitoring waiting times increased during
the summer due to seasonal staffing issues (data not
shown). Clearly, demand and capacity remain an
issue within this service. A solution to combat these
longer waiting times could be to increase the ca-
pacity of arrhythmia monitors or by considering al-
ternative strategies to either increase overall ca-
pacity or flexibility in the system. It should be not-
ed that cases with higher risk features were
prioritised on an ad hoc basis and this may have con-
tributed to the variation in waiting times.
The predominant provider of healthcare in the
UK is the NHS. The majority of staff are therefore
on a fixed salary or contracted to undertake work. In
the north of Scotland there is minimal private health
care provision. Thus, in general, demand outstrips
capacity in our healthcare system and there is a drive
to create more efficient ways of working within limi-
ted resources. However, this model may not be at-
tractive in other healthcare systems, especially
where there is predominantly private healthcare or
there is a fee for service contract.
Alternative models
The optimum mechanism for assessing and
investigating low risk patients with suspected arrhyth-
mia is not known. Potential alternative models to tra-
ditional review in clinic include rapid access clinics [8],
testing in primary care [9], or nurse led arrhythmia
clinics [10]. Each of these options has pros and cons.
While our current model seemed to be efficient in
terms of reducing consultant workload, there re-
mained an issue with waiting times and physical ac-
cess to the hospital for remote patients. The current
service has long waiting times for both Holter and
event monitors. Furthermore, our hospital serves
a dispersed population and thus there are geographi-
cal barriers to patients attending hospital. These are
compelling reasons to consider other models.
Nurse led arrhythmia clinics have been used
in the past. They are very similar to the current
direct access system, in that it is a non-cardiologist
with training in arrhythmia monitoring who carries
out the testing and interprets the results. It is ac-
cepted that nurse led clinics divert those with low
Figure 2. Patient outcomes following attendance at the
arrhythmia monitoring service; GP — general practitioners.
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risk palpitation symptoms away from the cardiology
clinic. However, in one study of 389 patients who
visited a nurse led clinic, 20 patients with high risk
features had to wait on average 70 extra days to be
seen by a cardiologist when compared with those
who were seen directly by a cardiologist [10]. A nurse
led service does not address monitor capacity issues,
and may be a relatively expensive model.
Primary care testing was the subject of an ar-
ticle in 2009 [9], where a 24 h and seven day ECG
monitoring service was introduced to the North
East Essex Primary Care Trust covering 52 prac-
tices. Eight practices in the area offer primary care
testing and accept patients from the whole Prima-
ry Care Trust. Testing was carried out by the prac-
tice and the recordings sent electronically to be an-
alyzed elsewhere by either a consultant or a private
company. The aim was to reduce the number of low
risk palpitation patients attending secondary care.
Those thought to be high risk were referred to se-
condary care. Around 80% of the patients were
found to have no abnormality, and the primary care
testing had therefore prevented the need for refer-
ral to secondary care. However, to set up such a ser-
vice requires start-up costs in terms of buying the
testing equipment, continuous costs in terms of
analyzing the tapes, and the need for GPs to have
an interest in cardiology. Primary care testing
would certainly overcome some of the geographi-
cal barriers faced by remote populations distant
from secondary care services. Indeed, at least ten
practices in our area already have monitors for ar-
rhythmia monitoring. However, to maintain high
quality of monitoring and interpretation of results,
monitors must be fitted correctly to obtain high
quality diagnostic recordings and there are concerns
that those carrying out such testing infrequently
may not develop, or may lose, skills that are more
easily achieved in large hospitals. Internal review
and quality monitoring may also be more challeng-
ing in a dispersed service.
A hospital based rapid access arrhythmia clinic
could be an effective way of carrying out arrhyth-
mia monitoring and should ensure patients are seen
quickly. The current monitor waiting times in this
study were considerable, and a regular rapid access
clinic might cut these times. However, such a cli-
nic would need significant resources in terms of
staff and equipment. Furthermore, the current
study demonstrated that 96% did not need specialist
advice, and in our remote area a centralized service
would offer less equitable access compared to pri-
mary care testing.
Limitations of the study
This study reports the experience of a single
center and thus may not be representative of other
areas. Nevertheless, the cohort was large, based in
a NHS regional centre and studied over a long pe-
riod, and thus we believe it is representative of the
general cardiology population in the UK, although
the situation in other countries may differ.
Conclusions
Direct access for cardiac arrhythmia monitoring
seems to provide an effective mechanism for suc-
cessfully diverting patients away from formal review
at a cardiology clinic. Challenges remain within
a busy NHS department in ensuring that waiting
times remain low. Alternative approaches could be
considered in areas with remote populations.
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